Roswell Park, Generate Biomedicines Launch Ovarian Cancer Trial
Generate Biomedicines Inc. and Roswell Park Comprehensive Cancer Center have launched an exclusive clinical trial for an 'armored' CAR T-cell therapy aimed at treating ovarian cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.